Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery

NCT: NCT07091396 · ACTIVE_NOT_RECRUITING

NCT IDNCT07091396
StatusACTIVE_NOT_RECRUITING
Start Date2026-01-16
Completion2031-12
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the feasibility of home-based Transcranial Direct Current Stimulation (tDCS) combined with a home activity based therapy program in patients with stroke, brain tumors or neurodegenerative conditions and to assess the efficacy of home-based tDCS combined with a home activity-based therapy program as an intervention to treat cognitive-linguistic impairments related to stroke, brain tumors, or neurodegenerative conditions and improve quality of life.

Frequently Asked Questions

What is Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery?

Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery is a clinical trial registered under NCT07091396. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07091396?

The current status of NCT07091396 (Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery) is: ACTIVE_NOT_RECRUITING.

When did Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery start?

Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery started on 2026-01-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.